Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adrenal Gland Pheochromocytoma”

167 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 167 results

Testing effectiveness (Phase 2)UnknownNCT05133349
What this trial is testing

A Prospective Phase II Efficacy and Safety Study of Anlotinib in Metastatic or Locally Advanced Pheochromocytoma/ Paraganglioma : Open-label Single-arm, Exploratory Trial

Who this might be right for
Advanced or Metastatic Paraganglioma/ Pheochromocytoma
Nanjing First Hospital, Nanjing Medical University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06607692
What this trial is testing

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Who this might be right for
Solid Tumor CancerMedulloblastomaHigh Risk Neuroblastoma+19 more
Fundación de investigación HM 25
Testing effectiveness (Phase 2)WithdrawnNCT06233903
What this trial is testing

18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System

Who this might be right for
NeuroblastomaPheochromocytomaParaganglioma
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
Not applicableStudy completedNCT07412158
What this trial is testing

Development and Clinical Application of a Novel Imaging Grading System for Pheochromocytoma and Paraganglioma (PPGL)

Who this might be right for
Risk Grading SystemPheochromocytoma and Paraganglioma (PPGL)Quantitative Assessment
Peking University First Hospital 500
Not applicableEnrolling By InvitationNCT03474237
What this trial is testing

A Prospective Cohort Study for Patients With Adrenal Diseases

Who this might be right for
Adrenal AdenomaCushing SyndromePheochromocytoma+3 more
Seoul National University Hospital 1,500
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Early research (Phase 1)Ended earlyNCT04895748
What this trial is testing

DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies

Who this might be right for
Carcinoma, Renal Cell
Novartis Pharmaceuticals 40
Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Not applicableEnded earlyNCT05456997
What this trial is testing

Metabolic Myopathy in Endocrinopathy

Who this might be right for
Cushing SyndromePheochromocytomaConns Syndrome+1 more
Barts & The London NHS Trust 1
Not applicableEnrolling By InvitationNCT06870396
What this trial is testing

National Study of Adrenal Tumours

Who this might be right for
Pheochromocytoma and Paraganglioma (PPGL)Adrenocorticol Cancer (ACC)Adrenal Tumours
Society for Endocrinology 300
Post-approval studies (Phase 4)Study completedNCT01959711
What this trial is testing

Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy

Who this might be right for
Adrenal TumorPheochromocytomaConn's Syndrome+1 more
Jagiellonian University 65
Testing effectiveness (Phase 2)Looking for participantsNCT07167329
What this trial is testing

Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial

Who this might be right for
Von Hippel LindauVon Hippel Lindau DiseaseVon Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma+5 more
José Claudio Casali da Rocha 100
Testing effectiveness (Phase 2)Looking for participantsNCT07680205
What this trial is testing

An Experimental Study of Belzutifan Impact on Catecholamine Metabolism

Who this might be right for
Pheochromocytoma and Paraganglioma (PPGL)Pheochromocytoma MalignantPheochromocytoma, Metastatic+2 more
Cambridge University Hospitals NHS Foundation Trust 12
Testing effectiveness (Phase 2)Study completedNCT03008369
What this trial is testing

Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery

Who this might be right for
Malignant Adrenal Gland PheochromocytomaMalignant ParagangliomaMetastatic Adrenal Gland Pheochromocytoma
Mayo Clinic 3
Testing effectiveness (Phase 2)Study completedNCT01371201
What this trial is testing

First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma

Who this might be right for
Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL)
Gustave Roussy, Cancer Campus, Grand Paris 78
Not applicableUnknownNCT03158870
What this trial is testing

Surgeon-Anesthesiologist Collaboration

Who this might be right for
PheochromocytomaCollaboration
Hospices Civils de Lyon 1,122
Testing effectiveness (Phase 2)Looking for participantsNCT04924075
What this trial is testing

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

Who this might be right for
Pheochromocytoma/ParagangliomaPancreatic Neuroendocrine TumorVon Hippel-Lindau Disease+2 more
Merck Sharp & Dohme LLC
Not applicableLooking for participantsNCT06813742
What this trial is testing

18F-mFBG PET Imaging in the Evaluation of Pheochromocytoma

Who this might be right for
Pheochromocytoma
First Affiliated Hospital of Zhejiang University 80
Not applicableWithdrawnNCT04770831
What this trial is testing

Patients Who Receive 131 I-MIBG

Who this might be right for
Brain and Nervous System
Wake Forest University Health Sciences
Not applicableApproved For MarketingNCT01377532
What this trial is testing

Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma

Who this might be right for
PheochromocytomaParaganglioma
University of California, San Francisco
Next Page
355